Evaxion A (EVAX) Interest & Investment Income (2020 - 2026)
Evaxion A (EVAX) reported Interest & Investment Income of $305000.0 for Q1 2026, down 87.77% on a YoY basis from $2.5 million in Q1 2025, and down 95.2% quarter-over-quarter from $6.4 million in Q4 2025.
Evaxion A (EVAX) Interest & Investment Income (2020 - 2026) Analysis & Trends
Evaxion A has reported Interest & Investment Income for 7 years, with the latest figure at $305000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 87.77% year-over-year to $305000.0; the trailing twelve-month figure through Mar 2026 stood at $305000.0 (down 87.77% YoY), and the FY2025 full-year result was $6.4 million, down 2.23% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $305000.0, down from $6.4 million in the prior quarter.
- The five-year high for Interest & Investment Income was $6.4 million in Q4 2025, with the low at $285000.0 in Q1 2023.
- Historically, Interest & Investment Income has averaged $3.0 million across 5 years, with a median of $2.6 million in 2022.
- Annual changes were most pronounced in 2024 — Interest & Investment Income surged 1871.23% — and 2026, when it tumbled 87.77%.
- Evaxion A's Interest & Investment Income stood at $2.8 million in 2022, then slumped by 85.37% to $404000.0 in 2023, then soared by 1365.84% to $5.9 million in 2024, then increased by 7.31% to $6.4 million in 2025, then slumped by 95.2% to $305000.0 in 2026.
- The last three Interest & Investment Income figures came in at $305000.0 (Q1 2026), $6.4 million (Q4 2025), and $5.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 305,000.00 |
| Dec 31, 2025 | 6.36 Mn |
| Sep 30, 2025 | 5.73 Mn |
| Jun 30, 2025 | 3.04 Mn |
| Mar 31, 2025 | 2.49 Mn |
| Sep 30, 2024 | 5.92 Mn |
| Jun 30, 2024 | 5.84 Mn |
| Mar 31, 2024 | 5.62 Mn |
| Sep 30, 2023 | 404,000.00 |
| Jun 30, 2023 | 332,000.00 |
| Mar 31, 2023 | 285,000.00 |
| Sep 30, 2022 | 2.76 Mn |
| Jun 30, 2022 | 2.06 Mn |
| Mar 31, 2022 | 519,000.00 |
| Sep 30, 2021 | 1.29 Mn |
| Jun 30, 2021 | 1.01 Mn |
| Mar 31, 2021 | 972,000.00 |
| Sep 30, 2020 | 122,000.00 |
| Jun 30, 2020 | 22,000.00 |
| Mar 31, 2020 | 16,000.00 |